scispace - formally typeset
N

Nancy L. Saccone

Researcher at Washington University in St. Louis

Publications -  133
Citations -  14273

Nancy L. Saccone is an academic researcher from Washington University in St. Louis. The author has contributed to research in topics: Smoking cessation & Genome-wide association study. The author has an hindex of 46, co-authored 127 publications receiving 13022 citations. Previous affiliations of Nancy L. Saccone include Harvard University.

Papers
More filters
Journal ArticleDOI

Assessment of genotype imputation performance using 1000 Genomes in African American studies.

TL;DR: Imputation quality for most programs was reduced by the addition of more distantly related reference populations, due entirely to the introduction of low frequency SNPs (MAF≤2%) that are monomorphic in the more closely related panels.
Journal ArticleDOI

Interplay of genetic risk factors and parent monitoring in risk for nicotine dependence

TL;DR: The genetic risk of nicotine dependent associated with rs16969968 was modified by level of parent monitoring, while the genetic risk associated withrs3743078 was not, suggesting that the increased risk due to some genes may be mitigated by environmental factors such as parent monitoring.
Journal ArticleDOI

Associations and interactions between SNPs in the alcohol metabolizing genes and alcoholism phenotypes in European Americans

TL;DR: The large effect of rs1229984 on alcohol behavior is replicated, and although not common (MAF = 4%), this polymorphism may be highly relevant from a public health perspective in European Americans and may also affect alcohol behavior but requires replication.
Journal ArticleDOI

Genetic variation (CHRNA5), medication (combination nicotine replacement therapy vs. varenicline), and smoking cessation

TL;DR: Results from two complementary smoking cessation trials demonstrate inconsistent genetic results in the placebo arms, highlighting the need to compare the most effective pharmacotherapies with the same placebo control to establish pharmacogenetic evidence to aid decisions on medication choice for patients trying to quit smoking.